VerifyMe, Inc. reports earnings on May 13 against a backdrop of persistent price weakness and a borrow market that remains meaningfully tighter than its peers.
The most striking feature of the setup is the cost to borrow. At 28.9% annualised, borrow costs have held in a narrow band between 26% and 34% for the past six weeks — expensive for a stock with only 0.3% of its float sold short. That disconnect is the story. Short interest has collapsed by over 82% in the past month, falling from roughly 270,000 shares shorted in early April to just 38,400 today. Yet the borrow rate has barely moved. Lenders are not cutting their price even as demand evaporates — a signal that the lending market views this name as genuinely difficult to source. Availability in the lending pool is reasonably open at current utilisation levels, but the elevated cost acts as a persistent friction for anyone looking to initiate a short ahead of the print.
Price action reinforces the cautious tone. VRME has shed 17% over the past month and is down nearly 13% on the week, closing at $0.69. The slide has come despite a broader market recovery, and it leaves the stock sitting well below the $1.50 target carried by the only active analyst on record — Barrington Research, which raised its Outperform rating target to $1.50 in January 2026. That target now implies more than a doubling from current levels. Maxim Group also maintained a Buy in mid-2025 while trimming its target lower, part of a consistent pattern of analysts holding constructive ratings while steadily walking down their price expectations. The analyst consensus is technically a Buy, but the recent changes — all cuts or holds, never fresh upgrades — tell a more measured story than the headline rating suggests.
Ownership is heavily concentrated in a small number of insiders and related parties. Marshall Geller and associated entities hold a combined position representing the largest disclosed stakes, with LPL Financial and Adam Stedham's direct holdings rounding out the top five. The insider activity on record from January 2026 reflects routine award-and-sell patterns at the CEO and CIO level — small in dollar terms and not directionally meaningful. No material open-market buying stands out.
Past earnings prints have been modestly eventful. The most recent prior quarters produced a 4–5% one-day decline followed by a 7–10% slide over five days. The March 2026 event was an outlier with a slight one-day gain and a 7% five-day rally, though the data shows two events tied to the same date, suggesting one may be a duplicate.
Tomorrow's print is less a test of short positioning — which has already unwound sharply — and more a test of whether VRME can deliver operational progress credible enough to close the gap between a $0.69 stock and a Street that has been holding Buy ratings through a long decline.
See the live data behind this article on ORTEX.
Open VRME on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
